NAD+ decline is one of the most consistent molecular features of aging. This article explains the mechanism, what the Gomes et al. and Igarashi et al. research established, and where NMN supplementation fits in the context of longevity science.
NMN is best approached as a practical, evidence-led supplement decision. The goal is to understand mechanism, dose context, quality checks, and safety boundaries before changing a daily routine.
NMN is best approached as a practical, evidence-led supplement decision. The goal is to understand mechanism, dose context, quality checks, and safety boundaries before changing a daily routine.
NMN is best approached as a practical, evidence-led supplement decision. The goal is to understand mechanism, dose context, quality checks, and safety boundaries before changing a daily routine.
NMN is best approached as a practical, evidence-led supplement decision. The goal is to understand mechanism, dose context, quality checks, and safety boundaries before changing a daily routine.
By Alex Chen | Updated May 4, 2026
Aging isn't one thing. It's nine things — at least according to the "Hallmarks of Aging" framework published in Cell in 2013 and updated in 2023. Genomic instability. Telomere attrition. Epigenetic alteration. Loss of proteostasis. Deregulated nutrient sensing. Mitochondrial dysfunction. Cellular senescence. Stem cell exhaustion. Altered intercellular communication.
Read that list again. NAD+ decline isn't one of the nine hallmarks — but it's implicated in nearly all of them. That's what makes NAD+ biology so central to aging research. It's not a single pathway. It's infrastructure that supports the maintenance of multiple systems simultaneously.
This article is about what actually happens to NAD+ as you get older — the numbers, the mechanisms, and what the evidence says about whether NMN can meaningfully intervene. No anti-aging hype. No "fountain of youth" nonsense. Just the biology and the data.
The Numbers: NAD+ Decline by the Decade
Let's start with what's actually been measured. A 2015 analysis in Cell Metabolism quantified NAD+ concentrations in human skin tissue across age groups. The finding: NAD+ drops by roughly 50% between age 40 and 60. A 2016 Nature paper corroborated this across multiple tissue types, showing NAD+ levels in brain, liver, and muscle tissue all decline with age, though at slightly different rates.
Here's what the trajectory looks like:
The mechanism is a double-sided problem. On the production side: NAMPT — the enzyme that converts nicotinamide to NMN in the NAD+ salvage pathway — declines with age. This is partly due to circadian disruption (NAMPT expression is clock-controlled) and partly due to oxidative stress damaging the cellular machinery. On the consumption side: CD38 — an enzyme that degrades NAD+ — increases on immune cells with age. Chronic low-grade inflammation ("inflammaging") upregulates CD38, creating a NAD+ sink that drains the pool.
The net effect: you're producing less NAD+ and consuming more. It's a biochemical scissors that cuts from both directions.
The Nine Hallmarks and Where NAD+ Fits
Let's walk through how NAD+ decline connects to the biology of aging — not as a single magic bullet, but as infrastructure supporting multiple maintenance systems.
Mitochondrial Dysfunction (Hallmark #6)
NAD+ is the central electron carrier in the electron transport chain. When NAD+ is low, your mitochondria literally cannot produce as much ATP. This isn't theoretical — the 2021 Nature Aging study measured mitochondrial respiration in aged tissue and found it reduced by 40-60% compared to young tissue. NMN supplementation in that study restored mitochondrial function.
Genomic Instability (Hallmark #1)
Your DNA takes roughly 10,000-100,000 hits per day from oxidative stress, UV radiation, and replication errors. PARP enzymes repair this damage — and consume NAD+ in the process. One severely damaged DNA strand can eat 150 NAD+ molecules. When NAD+ is already low from aging, the repair capacity is diminished. More damage accumulates. More PARP is activated. More NAD+ is consumed. It's a downward spiral.
Epigenetic Alteration (Hallmark #3)
Your epigenome — the chemical tags (methylation, acetylation) that control which genes are expressed — drifts with age. Sirtuins (especially SIRT1) maintain epigenetic stability by removing acetyl groups from histones and transcription factors. Sirtuins require NAD+. When NAD+ drops, sirtuin activity drops with it, and the epigenome degrades. This is one of the reasons epigenetic clocks "tick" — the methylation patterns that drift with age are partly downstream of declining sirtuin function.
Cellular Senescence (Hallmark #7)
Senescent cells are cells that have stopped dividing but refuse to die — they sit in tissues, secreting inflammatory signals that damage neighboring cells. NAD+ supports the cellular machinery that clears senescent cells (through autophagy and immune surveillance). It also dampens the inflammatory secretions of senescent cells through SIRT1-mediated suppression of NF-kB. When NAD+ is low, both clearance and damage control weaken.
Deregulated Nutrient Sensing (Hallmark #5)
SIRT1 and SIRT3 are the NAD+-dependent proteins that sense cellular energy status and adjust metabolism accordingly. When NAD+ is adequate, they respond to fasting and exercise by shifting metabolism toward fat oxidation and cellular repair. When NAD+ is low, these metabolic sensors go blind — the cell behaves as if nutrients are always abundant, storing fat and suppressing repair pathways, even when conditions call for the opposite.
Can NMN Actually Slow Biological Aging?
This is the question everyone wants answered, and the honest answer is: we don't know yet — but the early signals are promising.
The most rigorous way to measure biological aging is through epigenetic clocks — algorithms that estimate your biological age based on DNA methylation patterns. The original Horvath clock (2013), the PhenoAge clock (2018), and the DunedinPACE clock (2022) all measure slightly different aspects of aging, but they're the gold standard for quantifying whether an intervention is actually affecting the aging process.
To date, no published human trial has measured epigenetic clock changes in response to NMN. Several are underway — including trials using the GrimAge and PhenoAge clocks — but results haven't been published yet. This means the strongest claim we can make about NMN and biological aging is: NMN improves the surrogate markers that epigenetic clocks track (insulin sensitivity, inflammatory markers, physical function), which is consistent with slowed biological aging, but direct clock evidence doesn't exist yet in published form.
Companies offering "biological age testing" alongside NMN — DoNotAge and others do this — are generating interesting real-world data, but self-selected populations and lack of placebo control make this evidence suggestive rather than definitive.
The Sirtuin Connection: Why NMN Alone Might Not Be Enough
This is an important nuance that most NMN content skips: NAD+ is necessary for sirtuin function, but it might not be sufficient. The sirtuin activation story involves:
- NAD+ availability: NMN provides this part. Without NAD+, sirtuins are idle.
- Sirtuin-activating compounds (STACs): Resveratrol, pterostilbene, and other polyphenols directly bind to and activate sirtuins. Even with abundant NAD+, sirtuins may need these activating signals to function at full capacity.
- Lifestyle signals: Fasting, exercise, and cold exposure all activate sirtuins through AMPK and other energy-sensing pathways.
This is the biological rationale for the NMN + resveratrol combination: NMN provides the fuel (NAD+), resveratrol presses the accelerator (sirtuin activation), and lifestyle provides the contextual signal that tells sirtuins what to do. Whether this combination is meaningfully better than NMN alone in humans hasn't been tested head-to-head, but the mechanistic logic is sound. Our longevity stacking guide covers the full protocol in detail.
Practical Takeaway: What NMN Can and Can't Do for Aging
What the evidence supports: NMN can restore declining NAD+ levels, which supports the fundamental maintenance systems (mitochondrial function, DNA repair, sirtuin activity) that naturally deteriorate with age. The human trials show improvements in insulin sensitivity, physical function, and sleep — all markers that decline with age and that NMN partially restores.
What the evidence doesn't support yet: NMN extending human lifespan. NMN reversing epigenetic age as measured by validated clocks. NMN preventing or treating specific age-related diseases. These are plausible extensions of the mechanism, but they haven't been demonstrated in published human trials.
My view after reading the literature: NMN is probably most effective when started in your 30s or 40s — before NAD+ levels have cratered — as a maintenance strategy. Starting at 65 is better than not starting, but the goalpost has already moved. Think of it like retirement savings: the earlier you start, the more the compound effect works in your favor. If you're in your 40s and starting to notice the first signs of age-related decline (slower recovery, less consistent energy, creeping metabolic changes), NMN makes the most sense. If you're 25 and feel invincible, NAD+ support probably isn't your limiting factor — sleep, nutrition, and exercise will give you a dramatically better return on investment.
I'd also strongly recommend reading about the other side of the stress-NAD+ equation: chronic stress depletes both magnesium and NAD+ simultaneously. And magnesium deficiency is so common that fixing it might address some of the same symptoms people attribute to low NAD+. Sometimes the simplest intervention is the right one.
References: Cell Metabolism (2015) 22(6):1065-1074; Nature (2016) 537:169-173; Nature Aging (2021) 1:347-362; Cell (2013) 155(7):1624-1638; Cell (2023) 186(2):243-278; Genome Biology (2013) 14:R115; Aging (2018) 10(4):573-591.
Evidence checklist
Shop This Protocol
Compare your routine
Compare your routine against BIOSUDO's evidence-led product pages before changing dose or timing: shop the collection, review the quality standard, read the brand protocol, and continue in the journal.
How to judge the evidence
For NMN and Aging: What Actually Happens to NAD+ As You Get Older — And Whether NMN Can Slow It Down, the practical question is not whether a single study sounds impressive. The useful question is whether the study population, dose, duration, outcome, and safety notes match the decision a reader is actually making. Human trials deserve more weight than animal or cell data, but even human trials can be narrow: age range, baseline nutrient status, training level, sleep quality, medication use, and trial length can all change how transferable the result is. A stronger article should therefore separate mechanism from measured outcomes, and measured outcomes from marketing claims. That distinction keeps the recommendation useful without turning a supplement into a promise.
Quality and label checks before buying
Before adding any supplement to a daily routine, check the label like a buyer and the batch record like an auditor. The Supplement Facts panel should make the active ingredient, serving size, and form easy to identify. The other-ingredients list should be short enough to understand. The brand should explain whether it tests for identity, microbes, heavy metals, and common contaminants, and whether those tests are connected to a lot number rather than a generic marketing badge. For BIOSUDO readers, the point is simple: a routine is only as strong as the product quality behind it.
A practical decision workflow
Use a three-step workflow. First, define the job: energy, sleep timing, stress load, training recovery, or label transparency. Second, match the ingredient to that job and look for human evidence that uses a comparable dose and duration. Third, decide what would count as success before changing the routine. That might be sleep latency, morning alertness, perceived stress, training recovery, or simply confidence that the label is understandable. If the goal cannot be measured in ordinary life, the routine is probably too vague to improve reliably.
What to track for two weeks
A short tracking window makes the routine less speculative. Write down the exact product, serving size, timing, sleep schedule, caffeine intake, training load, and any unusual stressors. Use the same notes every day so the pattern is comparable. For sleep topics, track bedtime, wake time, sleep latency, night waking, and morning alertness. For energy or recovery topics, track workout difficulty, next-day soreness, afternoon focus, and digestive tolerance. For quality topics, track the documents you can actually verify: COA availability, lot number, ingredient form, testing lab, and expiration date. The point is not to create a medical trial at home. The point is to avoid changing five variables at once and then guessing which one mattered.
When to pause and reassess
A responsible supplement routine includes a stop rule. Pause and reassess if the routine causes new digestive discomfort, unusual sleep disruption, headaches, rash, mood changes, or any symptom that feels out of pattern. Also reassess before combining multiple products that influence the same target, such as stress response, sleep pressure, stimulant load, or mineral intake. People who are pregnant, nursing, managing a diagnosed condition, preparing for surgery, or taking prescription medication should bring the label and dose plan to a qualified clinician. This is not a limitation of evidence-led supplementation. It is the basic discipline that keeps a wellness habit from becoming an uncontrolled experiment.
How BIOSUDO frames the decision
BIOSUDO articles are written to make the decision observable: what the ingredient is, what the evidence can and cannot say, what the label should disclose, and what a reader can check before buying. That framing matters because many supplement decisions are made from a headline, a social post, or a single impressive number. A better process starts with the intended job, then checks ingredient identity, dose, form, timing, and quality evidence. Only after those pieces fit should the product become part of a routine. That is why this article links back to BIOSUDO quality pages and related journal pieces instead of treating one article as a standalone answer.
References
- Gomes AP, et al. "Declining NAD+ Induces a Pseudohypoxic State Disrupting Nuclear-Mitochondrial Communication during Aging." Cell (2013) 155(7):1624–1638. doi:10.1016/j.cell.2013.11.037
- Irie J, et al. "Effect of Oral Administration of Nicotinamide Mononucleotide on Clinical Parameters and Nicotinamide Metabolite Levels in Healthy Japanese Men." Endocrine Journal (2020) 67(2):153–160. Search on PubMed
- Yoshino M, et al. "Nicotinamide Mononucleotide Increases Muscle Insulin Sensitivity in Prediabetic Women." Science (2021) 372(6547):1224–1229. doi:10.1126/science.abe9985
- Igarashi M, et al. "Chronic Nicotinamide Mononucleotide Supplementation Elevates Blood Nicotinamide Adenine Dinucleotide Levels and Alters Muscle Function in Healthy Older Men." npj Aging (2022) 8:3. doi:10.1038/s41514-022-00084-z
- Niu KM, et al. "The Impacts of Short-Term NMN Supplementation on Serum Metabolism, Fecal Microbiota, and Telomere Length in Pre-Aging Phase." Nutrients (2023) 15(3):755. doi:10.3390/nu15030755
- NIH Office of Dietary Supplements. "Niacin: Fact Sheet for Health Professionals." NIH ODS
- FDA. "Questions and Answers on Dietary Supplements." FDA.gov
Evidence checklist
Sources
Evidence checklist
Sources
Evidence checklist
| Check | What to verify | Why it matters |
|---|---|---|
| Ingredient identity | Match the active ingredient to the label | Avoids confusing similar compounds |
| Dose context | Compare serving size with human evidence | Keeps expectations tied to study design |
| Safety fit | Review medications, pregnancy, and health conditions | Reduces avoidable risk |
| Quality proof | Look for COA, contaminant testing, and lot traceability | Separates marketing from verification |